Diabetes (2006) 55:97887
Novo Nordisk said it remains confident in the benefit-risk profile of our GLP-1 medicines when used consistent with their indications and product labeling. But neither directly addressed a link between GLP-1 drugs and an altered sense of smell
Tsouristakis AI, Febres G, McMahon DJ, Tchang B, Conwell IM, Tsang AJ, et al
The funders had no role in study design, data collection, data analysis, decision to publish, or manuscript preparation
Protein-Sensing Receptors Increasing dietary protein content by 1015% promotes satiety, reduces overall calorie intake, and produces sustained weight loss in rodents and man, possibly due in part to the induced changes in circulating gut hormones (125127)
If gastrointestinal symptoms are intolerable, your doctor can adjust the treatment plan appropriately, which may include temporarily reducing the dose or considering alternative weight management strategies